Hinton Cynthia F, Mai Cara T, Nabukera Sarah K, Botto Lorenzo D, Feuchtbaum Lisa, Romitti Paul A, Wang Ying, Piper Kimberly Noble, Olney Richard S
Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Social and Scientific Systems, Silver Spring, Maryland, USA.
Genet Med. 2014 Jun;16(6):484-90. doi: 10.1038/gim.2013.177. Epub 2013 Dec 5.
The aim of this study was to describe the methods, cases, and initial results of a pilot project using existing public health data collection programs (birth defect surveillance or newborn screening) to conduct long-term follow-up of children with metabolic disorders.
California, Iowa, New York, and Utah expanded birth defect surveillance or newborn screening programs to collect long-term follow-up data on 19 metabolic disorders. Data elements to monitor health status and services delivered were identified, and record abstraction and data linkages were conducted. Children were followed up through to the age of 3 years.
A total of 261 metabolic cases were diagnosed in 1,343,696 live births (19.4 cases/100,000; 95% confidence interval = 17.1-21.8). Four deaths were identified. Children with fatty acid oxidation disorders had a higher percentage of health service encounters compared with children with other disorders of at least one health service encounter (hospitalization, emergency room, metabolic clinic, genetic service provider, or social worker) except for hospitalizations; children with organic acid disorders had a higher percentage of at least one hospitalization during their third year of life than children with other disorders.
Existing public health data programs can be leveraged to conduct population-based newborn screening long-term follow-up. This approach is flexible according to state needs and resources. These data will enable the states in assessing health burden, assuring access to services, and supporting policy development.
本研究旨在描述一个试点项目的方法、案例及初步结果,该项目利用现有的公共卫生数据收集项目(出生缺陷监测或新生儿筛查)对患有代谢紊乱的儿童进行长期随访。
加利福尼亚州、爱荷华州、纽约州和犹他州扩大了出生缺陷监测或新生儿筛查项目,以收集19种代谢紊乱的长期随访数据。确定了用于监测健康状况和所提供服务的数据元素,并进行了记录摘要和数据关联。对儿童进行随访直至3岁。
在1343696例活产中,共诊断出261例代谢病例(19.4例/10万;95%置信区间=17.1-21.8)。确定了4例死亡。与患有其他疾病的儿童相比,患有脂肪酸氧化紊乱的儿童至少有一次健康服务接触(住院、急诊室、代谢诊所、基因服务提供者或社会工作者)的比例更高,但住院情况除外;患有有机酸紊乱的儿童在其生命的第三年至少有一次住院的比例高于患有其他疾病的儿童。
可以利用现有的公共卫生数据项目进行基于人群的新生儿筛查长期随访。这种方法可根据各州的需求和资源进行灵活调整。这些数据将有助于各州评估健康负担、确保获得服务并支持政策制定。